Moolec Science (MLEC) Depreciation and Depletion (2023 - 2024)

Moolec Science (MLEC) reported Depreciation and Depletion of -$5032.0 for Q3 2024, down 24.15% on a YoY basis from -$6634.6 in Q4 2023, and down 100.09% sequentially from $5.8 million in Q2 2024.

Moolec Science (MLEC) Depreciation and Depletion (2023 - 2024) Analysis & Trends

Moolec Science (MLEC) has 2 years of Depreciation and Depletion data on file, last reported at -$5032.0 in Q3 2024.

  • For the quarter ending Q3 2024, Depreciation and Depletion fell 24.15% year-over-year to -$5032.0; the trailing twelve-month figure through Sep 2024 stood at $5.8 million (changed N/A YoY), and the FY2025 full-year result was $6.0 million, up 3.72% from the prior year.
  • Depreciation and Depletion eased to -$5032.0 in Q3 2024, from $5.8 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $5.8 million in Q2 2024 to a low of -$6646.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Oculis Holding AG 66,561.01 Bn 66,560.72 Bn - 196,658.72
2 Nanobiotix 1,899.87 Bn 1,899.81 Bn - -
3 Akari Therapeutics 1,045.06 Bn 1,045.06 Bn - -
4 BeOne Medicines 470.43 Bn 465.64 Bn 1.35 Bn 39.39 Mn
5 Vertex Pharmaceuticals 123.43 Bn 116.19 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 70.20 Bn 61.44 Bn 3.31 Bn -
7 Belite Bio 61.75 Bn 61.75 Bn - -
8 Argenx Se 56.15 Bn 50.96 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.56 Bn 34.55 Bn 959.66 Mn -
10 Moolec Science 5.21 Bn 5.21 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 -5,032.00
Sep 30, 2024 -5,032.00
Jun 30, 2024 5.81 Mn
Jun 30, 2024 5.81 Mn
Mar 31, 2024 -6,646.00
Mar 31, 2024 -6,646.00
Dec 31, 2023 -2,230.00
Dec 31, 2023 -2,230.00
Sep 30, 2023 -4,053.00
Sep 30, 2023 -4,053.00
Jun 30, 2023 4.94 Mn
Jun 30, 2023 4.94 Mn
Mar 31, 2023 425.00
Mar 31, 2023 425.00